Skip Nav Destination
Contributions to Oncology
Ifosfamide in Tumor Therapy: Satellite Symposium held at the 18th National Cancer Congress of the German Cancer Society, Munich, March 1986: Proceedings
Edited by
S.Karger AG
Volume
26
Status:
Available
ISBN electronic:
978-3-318-03409-7
ISBN print:
978-3-8055-4647-8
Discontinued Book Series:
Contributions to Oncology
Subject Area:
Further Areas
,
General Medicine
,
Hematology
,
Oncology
,
Pneumology
,
Women's and Children's Health
Publication date:
1987
Ifosfamide in Tumor Therapy: Satellite Symposium held at the 18th National Cancer Congress of the German Cancer Society, Munich, March 1986: Proceedings
Edited by: G.A. Nagel, S. Seeber, W.P. Brade
https://doi.org/10.1159/isbn.978-3-318-03409-7
ISBN (print): 978-3-8055-4647-8
ISBN (electronic): 978-3-318-03409-7
Publisher: S.Karger AG
Published: 1987
Download citation file:
Digital Version
Pay-Per-View Access
$128.00
Print Version
Ifosfamide in Tumor Therapy
$128.00
Table of Contents
-
I - X: Title Page / Contents / PrefaceByS. SeeberS. SeeberFrankfurt; Göttingen LeverkuseenSearch for other works by this author on:
-
1 - 11: The Basis of Modern Ifosfamide Therapy1: Introduction
-
12 - 21: Ifosfamide in Tumor Therapy — An OverviewByM. VariniM. VariniLugano, SwitzerlandSearch for other works by this author on:
-
22 - 52: Ifosfamide — Dosing and SchedulingByW. P. Bradea;W. P. BradeaaMedical Department, ASTA Pharma AG, Frankfurt, FRGSearch for other works by this author on:K. Herdrich;K. HerdrichaMedical Department, ASTA Pharma AG, Frankfurt, FRGSearch for other works by this author on:H. O. KleinbH. O. KleinbbDepartment of Oncology, University of Cologne, FRGSearch for other works by this author on:
-
53 - 59: Pharmacokinetics and Bioavailability of Oral Ifosfamide
-
60 - 68: Effectiveness of Ifosfamide on Human Tumor Cells in Culture Using a Monolayer Proliferation AssayByF. HölzelF. HölzelbDept. of Gynecology and Obstetrics, University of Hamburg, FRGSearch for other works by this author on:
-
69 - 75: Self-induction of Cyclophosphamide and Ifosfamide Metabolism by Repeated High-Dose TreatmentByT. Wagner;T. WagneraKlinik für Innere Medizin, Medizinische Universität zu Lübeck, FRGSearch for other works by this author on:G. EhningerG. EhningerbMedizinische Klinik, Universität Tübingen, FRGSearch for other works by this author on:
-
76 - 83: High-Dose Concurrent Mesna Infusion May Interfere with the Antitumor Activity of IfosfamideByE. A. Wist;E. A. WistaUniversity Hospital of Tromsø, NorwaySearch for other works by this author on:Ø. P. Solheim;Ø. P. SolheimbThe Norwegian Radium Hospital, Montebello, Oslo, NorwaySearch for other works by this author on:S. AamdalS. AamdalcNorsk Hydro’s Institute of Cancer Research, Montebello, Oslo, NorwaySearch for other works by this author on:
-
84 - 92: Kidney Tolerance of Ifosfamide in Combination with Mesna after Single-Dose Infusion and 5-Day Dose FractionationByA. W. Mondorf;A. W. MondorfaZentrum der Inneren Medizin der Universitätskliniken Frankfurt/M.,Search for other works by this author on:G. Wüst;G. WüstaZentrum der Inneren Medizin der Universitätskliniken Frankfurt/M.,Search for other works by this author on:P. Drings;P. DringsbKlinik für Thoraxerkrankungen in Heidelberg-Rohrbach,Search for other works by this author on:A. Klingen;A. KlingencAbteilung Mikrobiologie und Immunologic, Ruhruniversität Bochum, FRGSearch for other works by this author on:E W. FalkenbergE W. FalkenbergcAbteilung Mikrobiologie und Immunologic, Ruhruniversität Bochum, FRGSearch for other works by this author on:
-
93 - 104: Pharmacological and Toxicological Effects of Ifosfamide (Holoxan®) Combined with Mesna (Uromitexan®) in Different Murine Tumor ModelsByI. Fichtner;I. FichtnerAcademy of Sciences of the GDR, Central Institute of Cancer Research, Berlin-Buch, GDRSearch for other works by this author on:Ch. NowakCh. NowakAcademy of Sciences of the GDR, Central Institute of Cancer Research, Berlin-Buch, GDRSearch for other works by this author on:
-
105 - 113: Testing IFO/Mesna and VP-16 Combination Therapy in the P388 Leukemia ModelByCh. Nowak;Ch. NowakAcademy of Sciences of the GDR, Central Institute of Cancer Research, Berlin, GDRSearch for other works by this author on:G. Steinhoff;G. SteinhoffAcademy of Sciences of the GDR, Central Institute of Cancer Research, Berlin, GDRSearch for other works by this author on:W. ArnoldW. ArnoldAcademy of Sciences of the GDR, Central Institute of Cancer Research, Berlin, GDRSearch for other works by this author on:
-
114 - 124: A Phase-II Study of Ifosfamide in the Treatment of Recurrent Sarcomas and Pediatric TumorsByA Raynor;A RaynorbSurgery Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Md., USASearch for other works by this author on:S. Rosenberg;S. RosenbergbSurgery Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, Bethesda, Md., USASearch for other works by this author on:J. MiserJ. MiseraPediatric Branch,Search for other works by this author on:
-
125 - 130: A Regimen with Ifosfamide and Cis-Platinum in Osteosarcomas: A Phase-II StudyByR. Pinkerton;R. PinkertonCentre Léon Berard, Lyon, FranceSearch for other works by this author on:C. Provensal;C. ProvensalCentre Léon Berard, Lyon, FranceSearch for other works by this author on:M. Brunat-MentignyM. Brunat-MentignyCentre Léon Berard, Lyon, FranceSearch for other works by this author on:
-
131 - 138: 120-h Continuous Infusion of Ifosfamide Alone and in Combination with Cis-Platinurc in Children and Adolescents with Recurrent Ewing’s Sarcoma1ByV. Bier;V. BieraUniversitätskinderklinik Heidelberg, FRGSearch for other works by this author on:H. Jürgens;H. JürgensbUniversitätskinderklinik Düsseldorf, FRGSearch for other works by this author on:G. Etspüler;G. EtspülerbUniversitätskinderklinik Düsseldorf, FRGSearch for other works by this author on:U. Exner;U. ExnercOrthopädische Klinik Balgrist Zürich, SwitzerlandSearch for other works by this author on:J. Ritter;J. RittereUniversitätskinderklinik Münster, FRGSearch for other works by this author on:K. Winkler;K. WinklerfUniversitätskinderklinik Hamburg, FRGSearch for other works by this author on:U. GöbelbU. GöbelbbUniversitätskinderklinik Düsseldorf, FRGSearch for other works by this author on:
-
139 - 142: Treatment Results of Ifosfamide-Containing Regimens in Pediatric TumorsByJ. de Kraker;J. de KrakerEmma Kinderziekenhuis, The Netherlands Cancer Institute, Amsterdam, The NetherlandsSearch for other works by this author on:P. A. VoûteP. A. VoûteEmma Kinderziekenhuis, The Netherlands Cancer Institute, Amsterdam, The NetherlandsSearch for other works by this author on:
-
143 - 144: Treatment Results in Patients with Disseminated Soft-Tissue Sarcomas Using Adriamycin/DTIC and Ifosfamide/Cis-Platinum (Abstract)1ByP. Heinkele;P. HeinkeleAbteilung für Onkologie-Hämatologie, Medizinische Klinik der Universität Hamburg, FRGSearch for other works by this author on:M. Garbrecht;M. GarbrechtAbteilung für Onkologie-Hämatologie, Medizinische Klinik der Universität Hamburg, FRGSearch for other works by this author on:G. LempidakisG. LempidakisAbteilung für Onkologie-Hämatologie, Medizinische Klinik der Universität Hamburg, FRGSearch for other works by this author on:
-
145 - 152: Alternatives to CYVADIC Combination Therapy of Soft Tissue SarcomasByJ. H. Hartlapp;J. H. HartlappaMedizinische Universitätsklinik Bonn, FRGSearch for other works by this author on:H. J. Illiger;H. J. IlligerbStädt. Kliniken Oldenburg, FRGSearch for other works by this author on:H. WolterH. WolteraMedizinische Universitätsklinik Bonn, FRGSearch for other works by this author on:
-
153 - 158: Results of Ifosfamide Combination Chemotherapy in Patients with Advanced Soft Tissue SarcomasByR. Fuchs;R. FuchsII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:M. Schroeder;M. SchroederII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:M. WesterhausenM. WesterhausenII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:
-
159 - 167: Ifosfamide plus Adriamycin in Advanced Soft Tissue Sarcomas: Preliminary Results of the EORTC Phase-II Trial 62842ByJ. Schütte;J. SchütteInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:P. Dombernowsky;P. DombernowskyInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:A. Santoro;A. SantoroInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:W. Stewart;W. StewartInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:H. T. Mouridsen;H. T. MouridsenInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:R. Somers;R. SomersInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:A. T. van Oosterom;A. T. van OosteromInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:G. Blackledge;G. BlackledgeInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:D. Thomas;D. ThomasInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:R. SylvesterR. SylvesterInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:
-
168 - 175: Preclinical Chemosensitivity Studies with Human Soft Tissue Sarcomas in Nude MiceByV. Budach;V. BudachaDept. of Radiooncology, West German Tumor Center, Essen, FRGSearch for other works by this author on:M. Bamberg;M. BambergaDept. of Radiooncology, West German Tumor Center, Essen, FRGSearch for other works by this author on:M. E. Scheulen;M. E. ScheulenbDept. of Oncology, West German Tumor Center, Essen, FRGSearch for other works by this author on:N. Niederle;N. NiederlebDept. of Oncology, West German Tumor Center, Essen, FRGSearch for other works by this author on:U. KrauseU. KrausecDept. of Surgery, West German Tumor Center, Essen, FRGSearch for other works by this author on:
-
176 - 192: Studies of Chemotherapy in Cervical Cancer: West Midlands Collaborative Trials Investigating the Value of Ifosfamide Alone and in Combination RegimensByC Meanwell;C MeanwellaWest Midlands Cancer Research Campaign, Clinical Trials UnitbDepartments of Radiotherapy and Medical Oncology, Queen Elizabeth Hospital, Birmingham, UKSearch for other works by this author on:G. Blackledge;G. BlackledgeaWest Midlands Cancer Research Campaign, Clinical Trials UnitbDepartments of Radiotherapy and Medical Oncology, Queen Elizabeth Hospital, Birmingham, UKSearch for other works by this author on:J. Mould;J. MouldbDepartments of Radiotherapy and Medical Oncology, Queen Elizabeth Hospital, Birmingham, UKSearch for other works by this author on:T. Latief;T. LatiefbDepartments of Radiotherapy and Medical Oncology, Queen Elizabeth Hospital, Birmingham, UKSearch for other works by this author on:D. Spooner;D. SpoonerbDepartments of Radiotherapy and Medical Oncology, Queen Elizabeth Hospital, Birmingham, UKSearch for other works by this author on:S. Chetiyawardana;S. ChetiyawardanabDepartments of Radiotherapy and Medical Oncology, Queen Elizabeth Hospital, Birmingham, UKSearch for other works by this author on:N. Stuart;N. StuartaWest Midlands Cancer Research Campaign, Clinical Trials UnitbDepartments of Radiotherapy and Medical Oncology, Queen Elizabeth Hospital, Birmingham, UKSearch for other works by this author on:F. Lawton;F. LawtonaWest Midlands Cancer Research Campaign, Clinical Trials UnitSearch for other works by this author on:K. Kelly;K. KellyaWest Midlands Cancer Research Campaign, Clinical Trials UnitSearch for other works by this author on:J. KavanaghJ. KavanaghaWest Midlands Cancer Research Campaign, Clinical Trials UnitSearch for other works by this author on:
-
193 - 198: Phase-II Trial with Ifosfamide/Mesna 24 h Intravenously for the Treatment of Advanced Cancer of the CervixByC. Araujo;C. AraujoPoliclinico Ferroviario Central, Buenos Aires, ArgentinaSearch for other works by this author on:M. De Marco;M. De MarcoPoliclinico Ferroviario Central, Buenos Aires, ArgentinaSearch for other works by this author on:M. SaporitiM. SaporitiPoliclinico Ferroviario Central, Buenos Aires, ArgentinaSearch for other works by this author on:
-
199 - 209: The Treatment of Brain Metastases with a Combination of Ifosfamide, BCNU and Radiotherapy1ByE. Lange;E. LangeaRobert Janker Klinik, Fachklinik für Tumorerkrankungen, Bonn, FRG bKreiskrankenhaus Oberberg Nord, Strahlenklinik, Gummersbach, FRGSearch for other works by this author on:J. Schlechtingen;J. SchlechtingenaRobert Janker Klinik, Fachklinik für Tumorerkrankungen, Bonn, FRG bKreiskrankenhaus Oberberg Nord, Strahlenklinik, Gummersbach, FRGSearch for other works by this author on:W. ScheefW. ScheefaRobert Janker Klinik, Fachklinik für Tumorerkrankungen, Bonn, FRG bKreiskrankenhaus Oberberg Nord, Strahlenklinik, Gummersbach, FRGSearch for other works by this author on:
-
210 - 211: Chemotherapy of Metastatic Malignant Melanoma with Cis-Platinum/Ifosfamide or Cis-Platinum/Actinomycin D: (Abstract)1ByA. von Paleske;A. von PaleskeAbt. Onkologie-Hämatologie, Medizinische Klinik, Universitätskrankenhaus Hamburg-Eppendorf, FRGSearch for other works by this author on:M. Garbrecht;M. GarbrechtAbt. Onkologie-Hämatologie, Medizinische Klinik, Universitätskrankenhaus Hamburg-Eppendorf, FRGSearch for other works by this author on:D. K. HossfeldD. K. HossfeldAbt. Onkologie-Hämatologie, Medizinische Klinik, Universitätskrankenhaus Hamburg-Eppendorf, FRGSearch for other works by this author on:
-
212 - 218: Ifosfamide/Ftorafur in Advanced Gastrointestinal CancerBySt. Tanneberger;St. TannebergerCentral Institute for Cancer Research, Academy of Sciences of the GDR, Berlin-Buch, GDRSearch for other works by this author on:U. Müller;U. MüllerCentral Institute for Cancer Research, Academy of Sciences of the GDR, Berlin-Buch, GDRSearch for other works by this author on:N. Wiener;N. WienerCentral Institute for Cancer Research, Academy of Sciences of the GDR, Berlin-Buch, GDRSearch for other works by this author on:C. QuadtC. QuadtCentral Institute for Cancer Research, Academy of Sciences of the GDR, Berlin-Buch, GDRSearch for other works by this author on:
-
219 - 223: Ifosfamide/Mesna vs. Ifosfamide/Mesna plus Sequential Methotrexate-Fluorouracil for the Treatment of Colorectal CancerByC. Araujo;C. AraujoPoliclínico Ferroviario Central-Oncología, Buenos Aires, ArgentinaSearch for other works by this author on:M. De MarcoM. De MarcoPoliclínico Ferroviario Central-Oncología, Buenos Aires, ArgentinaSearch for other works by this author on:
-
224 - 233: Ifosfamide and Etoposide as Second-Line Therapy in Advanced Breast Cancer: (Abstract)1ByG. Hoffmann;G. HoffmannOnkologisches Zentrum, Klinikum Mannheim, FRGSearch for other works by this author on:P. Worst;P. WorstOnkologisches Zentrum, Klinikum Mannheim, FRGSearch for other works by this author on:M. E. HeimM. E. HeimOnkologisches Zentrum, Klinikum Mannheim, FRGSearch for other works by this author on:
-
234 - 255: The Role of Ifosfamide in Testicular CancerByH. -J. SchmollH. -J. SchmollHanover University Medical School, Div. of Hematology/Oncology, Dept. of Medicine, Hanover, FRGSearch for other works by this author on:
-
256 - 261: Ifosfamide Monotherapy in Testicular CancerByJ. H. Hartlapp;J. H. HartlappaMedizinische Universitätsklinik Bonn, FRGSearch for other works by this author on:L. Weißbach;L. WeißbachbKrankenhaus Am Urban, Urolog. Abteilung, BerlinSearch for other works by this author on:B. Horstmann-DubralB. Horstmann-DubralaMedizinische Universitätsklinik Bonn, FRGSearch for other works by this author on:
-
262 - 263: Results of Ifosfamide Treatment in Metastasized Renal Cell Cancer: (Abstract)1ByJ. Kühböck;J. KühböckII. Medical Department, University of Vienna, AustriaSearch for other works by this author on:P. Pötzi;P. PötziII. Medical Department, University of Vienna, AustriaSearch for other works by this author on:P. AigingerP. AigingerII. Medical Department, University of Vienna, AustriaSearch for other works by this author on:
-
264 - 277: VP-16 plus Ifosfamide plus Cis-Platinum (VIP) in Refractory Germ Cell Cancer1ByP.J. LoehrerP.J. LoehrerSection of Hematology-Oncology, Indiana University Hospital, Indianapolis, Ind., USASearch for other works by this author on:
-
278 - 293: Chemotherapy of Disseminated Non-Seminomatous Testicular Cancer and Metastatic Seminoma with Ifosfamide/Mesna1ByM. E. Scheulen;M. E. ScheulenInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:N. Niederle;N. NiederleInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:K. Höffken;K. HöffkenInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:J. Schütte;J. SchütteInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:S. Seeber;S. SeeberInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:C. G. SchmidtC. G. SchmidtInnere Universitätsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRGSearch for other works by this author on:
-
294 - 318: Ifosfamide in the Treatment of Bronchial CarcinomaByDrings P.Drings P.Abteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRGSearch for other works by this author on:
-
319 - 325: Bioavailability of Ifosfamide in Lung Cancer Patients1ByT. Cerny;T. CernyaDept. of Medical Oncology, Berne, Switzerland (T. Cerny is the recipient of an EORTC Research Fellowship) bDept. of Clinical Pharmacology, Christie Hospital and Holt Radium Institute, Manchester, UKSearch for other works by this author on:J. M. Margison;J. M. MargisonaDept. of Medical Oncology, Berne, Switzerland (T. Cerny is the recipient of an EORTC Research Fellowship) bDept. of Clinical Pharmacology, Christie Hospital and Holt Radium Institute, Manchester, UKSearch for other works by this author on:N. Thatcher;N. ThatcheraDept. of Medical Oncology, Berne, Switzerland (T. Cerny is the recipient of an EORTC Research Fellowship) bDept. of Clinical Pharmacology, Christie Hospital and Holt Radium Institute, Manchester, UKSearch for other works by this author on:P. M. WilkinsonP. M. WilkinsonaDept. of Medical Oncology, Berne, Switzerland (T. Cerny is the recipient of an EORTC Research Fellowship) bDept. of Clinical Pharmacology, Christie Hospital and Holt Radium Institute, Manchester, UKSearch for other works by this author on:
-
326 - 337: Combination Chemotherapy of Ifosfamide (IFO)/Mesna plus Etoposide (VP-16) in Human Bronchial Carcinomas Xenotransplanted into BALB/c-nu/nu MiceByW. Arnold;W. ArnoldAcademy of Sciences of GDR, Central Institute of Cancer Research, BerlinSearch for other works by this author on:Ch. Nowak;Ch. NowakAcademy of Sciences of GDR, Central Institute of Cancer Research, BerlinSearch for other works by this author on:H. Naundorf;H. NaundorfAcademy of Sciences of GDR, Central Institute of Cancer Research, BerlinSearch for other works by this author on:G. SteinhoffG. SteinhoffAcademy of Sciences of GDR, Central Institute of Cancer Research, BerlinSearch for other works by this author on:
-
338 - 339: Ifosfamide, Etoposide and Thoracic Radiotherapy for Small Cell Lung Cancer: (Abstract)1ByN. Thatcher;N. ThatcheraDept. of Medical Oncology, Christie Hospital, Manchester, UK bDept. of Thoracic Medicine, Wythenshawe Hospital, Manchester, UKSearch for other works by this author on:T. Cerny;T. CernyaDept. of Medical Oncology, Christie Hospital, Manchester, UK bDept. of Thoracic Medicine, Wythenshawe Hospital, Manchester, UKSearch for other works by this author on:P. V. Barber;P. V. BarberaDept. of Medical Oncology, Christie Hospital, Manchester, UK bDept. of Thoracic Medicine, Wythenshawe Hospital, Manchester, UKSearch for other works by this author on:K. B. CarrollK. B. CarrollaDept. of Medical Oncology, Christie Hospital, Manchester, UK bDept. of Thoracic Medicine, Wythenshawe Hospital, Manchester, UKSearch for other works by this author on:
-
340 - 341: A Randomized Trial for Alternating Polychemotherapy of Small Cell Lung Cancer: (Abstract)1ByC. Gropp;C. GroppaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:K. Havemann;K. HavemannaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:J. Klapsing;J. KlapsingaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:N. Victor;N. VictoraStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:R. Holle;R. HolleaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:P. Drings;P. DringsaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:H. G. Manke;H. G. MankeaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:K.S Hans;K.S HansaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:M. Schroeder;M. SchroederaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:M. HeimM. HeimaStädtisches Krankenhaus Gütersloh, FRG bMedizinische Klinik und Poliklinik der Philipps-Universität Marburg, FRG cZBMT (Rechenzentrum), Universität Heidelberg, FRG dAbteilung Innere Medizin-Onkologie, Thoraxklinik, Heidelberg-Rohrbach, FRG eEvangelische und Johanniter Krankenanstalten, Oberhausen FRG fII. Medizinische Klinik, St. Johannes-Hospital, Duisburg, FRG gKlinik Bergisch Land, Wuppertal, FRGSearch for other works by this author on:
-
342 - 352: Sequential Polychemotherapy Following Surgery for Small Cell Bronchial Carcinoma in a Large Multicenter Cooperative TrialByK. Karrer;K. KarreraInst, for Epidemiology of Neoplasms,Search for other works by this author on:H. Denck;H. DenckbI. Surgical Dept., and Ludwig Boltzmann Inst, for Clinical Oncology, Hospital Lainz, Vienna, AustriaSearch for other works by this author on:ISC Cooperative Lung Cancer Study GroupISC Cooperative Lung Cancer Study GroupSearch for other works by this author on:
-
353 - 362: Ifosfamide/Vindesine Chemotherapy in Primarily Resistant or Relapsed Small Cell Lung CancerByH. Höfeler;H. HöfelerWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:B. Schoetensack;B. SchoetensackWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:J. Kemper;J. KemperWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:G. Krüger;G. KrügerWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:U. Wandl;U. WandlWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:J. Schütte;J. SchütteWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:N. Niederle;N. NiederleWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:K. Höffken;K. HöffkenWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:C. G. SchmidtC. G. SchmidtWestdeutsches Tumorzentrum, Innere Universitätsklinik und Poliklinik (Tumorforschung), Universitätsklinikum Essen, FRGSearch for other works by this author on:
-
363 - 368: Ifosfamide in Patients with Recurrent Non-Small Cell Lung CancerByJ. H. Karstens;J. H. KarstensAbt. Strahlentherapie, Medizinische Fakultät, Klinikum RWTH, Aachen, FRGSearch for other works by this author on:R. Keulers;R. KeulersAbt. Strahlentherapie, Medizinische Fakultät, Klinikum RWTH, Aachen, FRGSearch for other works by this author on:J. AmmonJ. AmmonAbt. Strahlentherapie, Medizinische Fakultät, Klinikum RWTH, Aachen, FRGSearch for other works by this author on:
-
369 - 371: Treatment of Unresectable Non-Small Cell Lung Cancer (NSCLC) with Cis-Platinum/Ifosfamide/VindesineByM. Schroeder;M. SchroederII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:W. Wellens;W. WellensII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:M. WesterhausenM. WesterhausenII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:
-
372 - 374: Karnofsky-Adapted Chemotherapy of Non-Small Cell Lung Cancer with Ifosfamide/Mitomycin C/VindesineByM. Schroeder;M. SchroederII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:A. Brunöhler;A. BrunöhlerII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:H. Vaupel;H. VaupelII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:L. Leimer;L. LeimerII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:G. Eilers;G. EilersII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:M. WesterhausenM. WesterhausenII. Med. Klinik, St. Johannes-Hospital, Duisburg, FRGSearch for other works by this author on:
-
375 - 393: Combination Chemotherapy with Mitomycin C, Ifosfamide, and Vindesine in the Treatment of Non-Small Cell Lung CancerByU. Gatzemeier;U. GatzemeieraDepartment of Pneumological Oncology, Großhansdorf Hospital, FRGSearch for other works by this author on:D. K. Hossfeld;D. K. HossfeldbDepartment of Hematology and Oncology, University of Hamburg, FRGSearch for other works by this author on:H. Magnussen;H. MagnussenaDepartment of Pneumological Oncology, Großhansdorf Hospital, FRGSearch for other works by this author on:D. Radenbach;D. RadenbachaDepartment of Pneumological Oncology, Großhansdorf Hospital, FRGSearch for other works by this author on:
-
394 - 399: Ifosfamide Combinations in the Management of LymphomasByF. CabanillasF. CabanillasDept. of Hematology, Section of Lymphoma, M. D. Anderson Hospital and Tumor Institute, Houston, Tex., USASearch for other works by this author on:
-
400 - 407: The BMV-VIP Regime in the Treatment of Refractory LymphomataByS. Retsas;S. RetsasMedical Oncology Unit, Westminster Hospital, London, UKSearch for other works by this author on:C. BaughanC. BaughanMedical Oncology Unit, Westminster Hospital, London, UKSearch for other works by this author on:
-
408 - 413: IMP-M (Ifosfamide, Methotrexate, VP-16, and Mesna) in the Treatment of Previously Heavily Treated Patients with Malignant LymphomaByY. Cohen;Y. CohenaDept. of Oncology, Rambam Medical Centre, Haifa, IsraelbSoroka Medical Centre, Beer Sheva, IsraelSearch for other works by this author on:R. Epelbaum;R. EpelbaumaDept. of Oncology, Rambam Medical Centre, Haifa, IsraelSearch for other works by this author on:M. MuattiM. MuattiaDept. of Oncology, Rambam Medical Centre, Haifa, IsraelSearch for other works by this author on:
-
414 - 422: Combination Chemotherapy with Etoposide (VP-16), Ifosfamide, Methotrexate,and Bleomycin (VIM(B)) for Refractory or Recurrent LymphomasByM. R. Nowrousian;M. R. NowrousianDepartment of Internal Medicine (Cancer Research), West German Tumor Center, University of Essen, FRGSearch for other works by this author on:B. Schoetensack;B. SchoetensackDepartment of Internal Medicine (Cancer Research), West German Tumor Center, University of Essen, FRGSearch for other works by this author on:R. Pfeiffer;R. PfeifferDepartment of Internal Medicine (Cancer Research), West German Tumor Center, University of Essen, FRGSearch for other works by this author on:N. Niederle;N. NiederleDepartment of Internal Medicine (Cancer Research), West German Tumor Center, University of Essen, FRGSearch for other works by this author on:Ch. Anders;Ch. AndersDepartment of Internal Medicine (Cancer Research), West German Tumor Center, University of Essen, FRGSearch for other works by this author on:S. Seeber;S. SeeberDepartment of Internal Medicine (Cancer Research), West German Tumor Center, University of Essen, FRGSearch for other works by this author on:C. G. SchmidtC. G. SchmidtDepartment of Internal Medicine (Cancer Research), West German Tumor Center, University of Essen, FRGSearch for other works by this author on:
-
423 - 424: Ifosfamide, Vincristine and Prednisone in Non-Hodgkin’s Lymphoma: (Abstract)ByN. Gad-El-Mawla;N. Gad-El-MawlaNational Cancer Institute, Cairo, EgyptSearch for other works by this author on:M. R. Hamza;M. R. HamzaNational Cancer Institute, Cairo, EgyptSearch for other works by this author on:H. El-ZawahryH. El-ZawahryNational Cancer Institute, Cairo, EgyptSearch for other works by this author on:
-
425 - 430: Combination of Ifosfamide,Methotrexate, VP-16, and Bleomycin (IMV-BLEO) as Salvage Therapy for Non-Hodgkin’s LymphomaByF. W. Busch;F. W. BuschaMed. Univ.-Klinik Abt. II, Tubingen, FRGSearch for other works by this author on:H. U. Krüger;H. U. KrügeraMed. Univ.-Klinik Abt. II, Tubingen, FRGSearch for other works by this author on:M. Heim;M. HeimcKlinikum Mannheim, Onkologisches Zentrum, Mannheim, FRGSearch for other works by this author on:E. Güntherd;E. GüntherddKreiskrankenhaus Reutlingen, Innere Abteilung, Reutlingen, FRGSearch for other works by this author on:B. SteinkeB. SteinkeaMed. Univ.-Klinik Abt. II, Tubingen, FRGSearch for other works by this author on:
-
431 - 437: Salvage Chemotherapy with Ifosfamide, Bleomycin, Etoposide, and Procarbazine (IBEP) in CHOP-Resistant Non-Hodgkin’s Lymphomas
-
438 - 452: Results of a New Drug Combination (VP-16 — Ifosfamide — Mitoxantrone — Bleomycin/VIM-BLEO) in Advanced Non-Hodgkin’s LymphomasByR. Heinz;R. Heinza3.Medizinische Abteilung und Ludwig-Boltzmann-Institut für Leukämieforschung, Hanusch-Krankenhaus, Vienna, AustriaSearch for other works by this author on:Ch. Dittrich;Ch. DittrichbUniversitätsklinik für Chemotherapie, Vienna, AustriaSearch for other works by this author on:H. Ludwig;H. LudwigbUniversitätsklinik für Chemotherapie, Vienna, AustriaSearch for other works by this author on:J. Kühbóck;J. KühbóckcII. Medizinische Universitätsklinik, Vienna, AustriaSearch for other works by this author on:M. Wirth;M. WirthdI. Medizinische Abteilung, Krankenhaus Rudolfstiftung, Vienna, AustriaSearch for other works by this author on:G. Baumgartner;G. Baumgartnera3.Medizinische Abteilung und Ludwig-Boltzmann-Institut für Leukämieforschung, Hanusch-Krankenhaus, Vienna, AustriaSearch for other works by this author on:R. Waldner;R. Waldnera3.Medizinische Abteilung und Ludwig-Boltzmann-Institut für Leukämieforschung, Hanusch-Krankenhaus, Vienna, AustriaSearch for other works by this author on:J. Schüller;J. SchüllerdI. Medizinische Abteilung, Krankenhaus Rudolfstiftung, Vienna, AustriaSearch for other works by this author on:Vienna Lymphoma Study GroupVienna Lymphoma Study GroupSearch for other works by this author on:
-
453 - 455: Final RemarksByS. SeeberS. SeeberZentrum für Innere Medizin, Medizinische Klinik III, Leverkusen, FRGSearch for other works by this author on:
